Salvage therapy outcomes for atypical meningioma
- 26 February 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 138 (2) , 425-433
Abstract
Atypical menginomas demonstrate increased clinical aggressiveness characterized by recurrence and diminished survival. The optimal management of atypical meningioma in the recurrent setting is especially not well defined. To characterize outcomes following salvage treatment of recurrent atypical meningioma and to identify risk factors for further recurrence. Retrospective chart review was performed on 65 patients who underwent salvage treatment of atypical meningioma at a single institution. Data were analyzed using the Kaplan–Meier method and Cox proportional hazards modeling. Sixty-five patients with recurrent atypical meningioma and median imaging follow-up of 4.0 years (range 1.9–6.6 years) underwent 62 surgeries and 114 radiation treatments (RT) for salvage therapy. Salvage modality was surgery (21%), surgery/RT (25%), or RT alone (54%), associated with 2 year local freedom from recurrence (LFFR) of 36, 59, and 73%, respectively (P = 0.01). Twenty percent of patients experienced CTCAE grade ≥ 3 toxicity with salvage therapy. Thirty-nine percent of patients experienced ≥ 3 recurrences. The median disease-free survival intervals after first and second salvage treatments were 2.9 and 1.3 years, respectively. On univariate Cox analysis, prior subtotal resection, prior RT, tumor diameter > 2.5 cm, and multifocal local recurrence were associated with recurrence after salvage therapy. On multivariate logistic regression, only multifocal local recurrence was associated with further recurrence. Recurrent atypical meningioma is clinically and pathologically more aggressive than primary atypical meningioma, and the likelihood of durable local control with salvage therapy is lower. Future efforts should identify patients at risk of recurrence, and aggressive upfront treatment should be employed.Keywords
Funding Information
- Linda Wolfe Meningioma Research Fund
- National Institutes of Health (1F32CA213944-01)
This publication has 37 references indexed in Scilit:
- The role of radiotherapy following gross-total resection of atypical meningiomasJournal of Neurosurgery, 2012
- Systems modelling approaches to the design of safe healthcare delivery: ease of use and usefulness perceived by healthcare workersErgonomics, 2010
- LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATIONNeurosurgery, 2009
- Review of meningioma histopathologyNeurosurgical Focus, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Prevalence estimates for primary brain tumors in the United States by behaviour and major histology groupsNeuro-Oncology, 2001
- Repeated multifocal recurrence of grade I, grade II, and grade III meningiomas: Regional multicentricity (primary new growth) or metastases?Surgical Neurology, 1994
- Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcomeSurgical Neurology, 1986
- Recurrence of intracranial meningiomas: the role played by regional multicentricityJournal of Neurosurgery, 1986
- The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patientsSurgical Neurology, 1985